Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001248852 | SCV002099097 | uncertain significance | Neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities | 2021-03-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001876295 | SCV002113474 | uncertain significance | not provided | 2022-06-04 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 972737). This missense change has been observed in individual(s) with GRM7-related leukodystrophy (PMID: 32286009). This variant is present in population databases (rs769709112, gnomAD 0.02%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 658 of the GRM7 protein (p.Arg658Gln). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Arg658 amino acid residue in GRM7. Other variant(s) that disrupt this residue have been observed in individuals with GRM7-related conditions (PMID: 27435318), which suggests that this may be a clinically significant amino acid residue. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. |
Breakthrough Genomics, |
RCV001876295 | SCV005187494 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV001248852 | SCV001422474 | pathogenic | Neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities | 2023-09-11 | no assertion criteria provided | literature only |